This section is The content in this section is supplied by GlobeNewswire for the purposes of distributing press releases on behalf of its clients. Postmedia has not reviewed the content. by GlobeNewswire Article content
Vancouver, BC, Sept. 09, 2026 (GLOBE NEWSWIRE) — Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI” or the “Company”), a physician-built, AI-powered healthcare technology company focused on empowering doctors and expanding access to high-quality care, is pleased to announce that it will host a comprehensive Company Town Hall on Monday, September 14, 2026.
Sign In or Create an Account
or View more offersArticle content
The virtual event will be co-led by Dr. Essam Hamza, CEO Rocket Doctor AI Inc. and Dr. William Cherniak Founder and CEO, Rocket Doctor Inc., who will provide a strategic retrospective overview of Rocket Doctor’s operational successes and key highlights in Q2 2026, and articulate the Company’s growth strategy for the United States and Canada for the remainder of 2026.
Article contentWe apologize, but this video has failed to load.Try refreshing your browser, or
tap here to see other videos from our team.Article content
Story continues below
This advertisement has not loaded yet, but your article continues below.
Article content
Event Details
Article contentArticle content
- What: Rocket Doctor AI Inc. Company Town Hall
- When: Monday, September 14, 2026
- Time: 1300 Pacific Standard Time/1600 Eastern Standard Time
- Link: Zoom Webinar: https://us06web.zoom.us/j/83081404618
- Who: Open to all Rocket Doctor AI team members, key stakeholders, investors and
strategic partners.
Article content
About Rocket Doctor AI Inc.
Article content
Rocket Doctor AI Inc. delivers physician-built, AI-powered solutions designed to make high-quality healthcare accessible throughout the entire patient journey. A cornerstone of the company’s proprietary technology is the Global Library of Medicine (GLM), a clinically validated decision support system developed with input from hundreds of physicians worldwide.
Article content
Alongside the GLM is Rocket Doctor Inc, and its AI-powered digital health platform and marketplace. Having helped empower over 350 MDs to provide care to more than 750,000 patient visits, our proprietary technology software and systems enable doctors to independently launch and manage their own virtual or hybrid in-person practices – improving efficiency, restoring autonomy to MDs, and expanding patient access to care.
Article content
Story continues below
This advertisement has not loaded yet, but your article continues below.
Article content
By reducing administrative burdens and ensuring greater consistency in care, our technology creates more time for meaningful physician-patient interactions. We are committed to reaching underserved, rural, and remote communities in Canada who often lack access to family doctors and supporting patients on Medicaid and Medicare in the United States. With advanced AI, large language models, and connected medical devices, Rocket Doctor AI is redefining modern healthcare – making it more scalable, equitable, and patient-centered.
Article content
To learn more about Rocket Doctor AI Inc’s products and services, contact: www.rocketdoctor.ai or email: [email protected]
Article content
FOR ADDITIONAL INFORMATION, CONTACT:
Article content
Dr. Essam Hamza, CEO, Rocket Doctor AI
[email protected]
Article content
Dr. William Cherniak, CEO, Rocket Doctor Inc.
[email protected]
Article content
For media inquiries, contact: [email protected]
Call: +1 (778) 819 8321
Article content
Cautionary Statements
Article content
This news release contains forward-looking statements relating to the future operations of Rocket Doctor AI Inc. and other statements that are not historical facts. Forward-looking statements are often identified by terms such as “will”, “may”, “should”, “anticipate”, “expects” and similar expressions. All statements other than statements of historical fact, included in this release, including, without limitation, statements regarding the Company Town Hall, the Company’s growth strategy for the United States and Canada, and future plans and objectives of Rocket Doctor AI Inc., are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from Rocket Doctor AI Inc.’s expectations include other risks detailed from time to time in the filings made by Rocket Doctor AI Inc. with securities regulators.